How Much Cheaper Is Generic Atorvastatin Than Lipitor?
Generic atorvastatin costs 80-90% less than brand-name Lipitor. A 30-day supply of generic atorvastatin (10-80 mg doses) typically runs $10-30 at major U.S. pharmacies with discounts, while Lipitor averages $150-300 for the same supply without insurance.[1][2]
Why the Price Gap Exists
Lipitor's patent expired in 2011, allowing generics from manufacturers like Ranbaxy, Mylan, and Watson to flood the market. This competition drove prices down quickly—generics hit the market at under 20% of Lipitor's cost within months. Brand Lipitor remains available but sees limited demand due to higher pricing tied to Pfizer's branding and any remaining exclusivities.[3]
Real-World Costs with Insurance or Discounts
- Cash pay: Generic 30-day supply: $4-15 at Walmart or $10 via GoodRx coupons. Lipitor: $200+.
- With insurance: Copays for generics often drop to $0-10; Lipitor copays range $30-50 or more.
- Mail-order/90-day: Generics fall to $5-20; Lipitor stays over $400.[2][4]
Prices fluctuate by dose, location, and pharmacy—check GoodRx or Drugs.com for local quotes.
When Does Lipitor's Patent Fully Expire?
Core U.S. patents on atorvastatin expired November 2011, with pediatric exclusivity ending shortly after. No major patents block generics today, though Pfizer holds minor formulation patents (expiring 2020s) irrelevant to standard generics.[5] DrugPatentWatch.com tracks full details.
Lipitor vs. Other Statin Generics
| Statin | Generic 30-Day Cost (10-20 mg) | Brand Equivalent Cost |
|--------|-------------------------------|----------------------|
| Atorvastatin | $10-20 | Lipitor: $200+ |
| Simvastatin | $5-15 | Zocor: $150+ |
| Rosuvastatin | $15-30 | Crestor: $300+ |
Atorvastatin generics rank among the cheapest statins, making them first-line for most patients.[1][6]
[1]: GoodRx.com, "Atorvastatin Prices" (accessed 2023).
[2]: Drugs.com, "Lipitor vs. Atorvastatin Cost Comparison."
[3]: FDA Orange Book, Atorvastatin Approvals.
[4]: Walmart Pharmacy Pricing Data.
[5]: DrugPatentWatch.com, Lipitor Patent Status.
[6]: IQVIA National Prescription Audit (2023 statin market share).